Fig. 8
From: Surface-modified cobalt oxide nanoparticles: new opportunities for anti-cancer drug development
Scanning electron microscopy shows the intracellular uptake of PMIDA-coated cobalt oxide nanoparticles into Jurkat and KB cell lines. a Jurkat control, b Jurkat + 25 μg/ml doxorubicin, c Jurkat + 25 μg/ml PMIDA-coated CoO nanoparticles, d KB control, e KB + 25 μg/ml doxorubicin, f KB + 25 μg/ml PMIDA-coated CoO nanoparticles